SJ830599

CAS No. 2215098-23-8

SJ830599( SJ 830599 )

Catalog No. M13530 CAS No. 2215098-23-8

SJ830599 is a modest selective BRD2-BD2 inhibitor with IC50 of 0.61 uM, 3.3-fold selectivity over BRD2-BD1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SJ830599
  • Note
    Research use only, not for human use.
  • Brief Description
    SJ830599 is a modest selective BRD2-BD2 inhibitor with IC50 of 0.61 uM, 3.3-fold selectivity over BRD2-BD1.
  • Description
    SJ830599 is a modest selective BRD2-BD2 inhibitor with IC50 of 0.61 uM, 3.3-fold selectivity over BRD2-BD1; demonstrates cytotoxicity against several pediatric cancer cell lines with EC50 values (HD-MB03 EC50=480 nM) comparable to BET inhibitor (BETi) clinical candidates.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SJ 830599
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2215098-23-8
  • Formula Weight
    356.422
  • Molecular Formula
    C20H24N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Isopropyl ((2S,4R)-1-acetyl-6-(furan-2-yl)-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)carbamate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shadrick WR, et al. Bioorg Med Chem. 2018 Jan 1;26(1):25-36.
molnova catalog
related products
  • BRD4 inhibitor Compo...

    BRD4 inhibitor Compound V is a domain-selective inhibitor of BRD4 with IC50 of 1.8 uM for BRD4 BD1, displays 6- and 16-fold selectivity for BRD4 over BRD2 and BRD3, respectively.

  • CPI-268456

    A bromodomain-?containing protein inhibitor.

  • LP99

    LP99 is the first potent and selective BRD7/9 bromodomain inhibitor with Kd of 99 nM for BRD9; inhibits IL‐6 secretion from THP‐1 cells in a dose‐dependent manner.